Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04789967
Other study ID # USM/JEPeM/20110562
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 25, 2021
Est. completion date August 30, 2022

Study information

Verified date November 2022
Source Universiti Sains Malaysia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

65% of the general population reported experiencing moderate to severe bloating symptoms. Bloating could be disturbing to patients and frustrating to the physicians as an effective treatment is still lacking. Guided Imagery (GI) involves the structured visualisation of mental images with somatic sensory; whereas Progressive Muscle Relaxation (PMR) focuses on tightening and relaxing the body's specific muscle groups. The development and validation of GI or PMR interventions to treat patients with functional abdominal bloating are relatively novel.


Description:

The baseline variables of the patient would be obtained at the outpatient Gastrointestinal Medical clinic. A thorough general clinical interview that encompasses medical and psychological history, discussion of the nature and severity of the current symptoms, and review of past treatments and conclusions of any medical evaluation and tests. This is to make sure that the patients have been comprehensively evaluated medically and to rule out other causes of abdominal bloating before reaching a firm diagnosis of functional abdominal bloating as suggested in ROME IV Criteria. Questionnaires will be given out and patients were asked to fill it up on the spot. Electrical activity and abdominal circumference would be measured at an enclosed space with appropriate privacy and accompanied by a chaperone.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date August 30, 2022
Est. primary completion date June 28, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Participants with abdominal bloating as determined using the Malay version Rome III criteria which was validated and translated by past researchers (Lee et al, 2012) and/or patients who were suggested by clinicians. - Participants must be 18 years and above, and of either gender. - Participants are able to read, write, or understand the Malay language. Exclusion Criteria: - Patients with abdominal bloating due to organic disorder - Patients with recent abdominal surgeries (within 3 months) or previous major abdominal surgeries - Patients with major neurological and psychological disorders including stroke, schizophrenia, major depression. - Patients with medical history which may be the red flag for other FGIDs and organic disorders . - Patients who are on psychotropic medications or psychotherapy which may confound outcome of imagery of sham intervention.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Guided Imagery
Individualized Guided Imagery (GI) technique, an alternative type of relaxation therapy. The content of GI usually includes scenery, places or any image projected to the mind. By using information generated, participants are guided to create a place in their mind using their senses of touch, sound, smell, sight and taste.
Progressive Muscle Relaxation
Progressive muscle relaxation (PMR) therapy works by progressively relaxing and tensing the muscle groups throughout the entire body. Each muscle group will be tensed for about 5 seconds. If there's any pain or discomfort at any of the targeted areas, participants were told to omit that particular step. Constant purposeful deep breathing was instructed throughout the session especially in between changes of muscle.
Other:
Educational Audiobook
Participants in the control group will receive an audiobook that targets to educate patients regarding gut-brain disorders, functional gastrointestinal disorders, causes of functional abdominal bloating, and treatment modalities available. Relaxing musical background will be added to facilitate the delivery.

Locations

Country Name City State
Malaysia Universiti Sains Malaysia Kubang Kerian Kelantan

Sponsors (1)

Lead Sponsor Collaborator
Universiti Sains Malaysia

Country where clinical trial is conducted

Malaysia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Symptoms severity Measured using the Malay version of Bloating Severity Questionnaire (BSQ-M). It consists of two components: five-item Sev24 and seven-item SevGen. The responses were in a multiple-choice answer format on different degrees of effect towards individuals on the basis of intensity, frequency and severity (less severe to more severe; range 1 to 4,5,6,7 or 8 varied by items). Higher scores in BSQ indicate worse severity. 1 month
Secondary Health belief Measured using the Malay-Language Health of Bloating (HB-Bloat) Scale. The questionnaire consists of 12 items and 3 domains: attitude (3 items), subjective norm (5 items), perceived control towards self-management (4 items). All responses were measured on a five-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). 1 month
Secondary Health seeking Intention Measured using Health Seeking Intention for Abdominal Bloating Scale. It is a 5 point Likert scale that consists of 1 domain and 1 item. 1 indicates "strongly diagree" while 5 indicates "strongly agree" 1 month
Secondary Health promoting behavior Measured using Health Promoting Behavior Scale of Abdominal Bloating. The questionnaire consists of 4 domains and 15 items. The questionnaire is a 5 point Likert scales, whereby 1 is considered strongly disagree and 5 is considered strongly agree. 1 month
Secondary Anxiety Measured using the Malay version of Hospital Anxiety and Depression Scale (HADS). It comprises of 14 items, seven of which is related to anxiety symptoms. Each item is coded from 0 to 3. The scores for anxiety and depression can therefore vary from 0 to 21, depending on the presence and severity of the symptoms. A score between 0 and 7 does not indicate the presence of the symptoms of anxiety; a score between 8 and 10 indicates the presence of a moderate symptom; a score of 11 and above indicates a significant number of symptoms of anxiety corresponding to confirmed cases. 1 month
Secondary Depression Measured using the Malay version of Hospital Anxiety and Depression Scale (HADS). It comprises of 14 items, seven of which is related to anxiety symptoms. Each item is coded from 0 to 3. The scores for anxiety and depression can therefore vary from 0 to 21, depending on the presence and severity of the symptoms. A score between 0 and 7 does not indicate the presence of the symptoms of anxiety; a score between 8 and 10 indicates the presence of a moderate symptom; a score of 11 and above indicates a significant number of symptoms of anxiety corresponding to confirmed cases. 1 month
Secondary Abdominal circumference Using a non-stretch metric tape 1 month
Secondary Electrical activity Measured using the Megawin ME6000 Electromyograph 1 month
Secondary Quality of life for patients with abdominal bloating Measured using the Malay version of Bloating Quality of Life (BLQoL-M) Questionnaires. The responses for BLQoL were in a 7-point Likert scale on different degrees of impact towards individual ranging from 1 = "never/not related to me" to 7 = "always". Higher scores in BLQoL indicate higher impact towards QoL. 1 month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05936112 - Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study N/A
Completed NCT02565355 - Targeted Food Elimination for Treatment of Functional Gastrointestinal Diseases in Children N/A
Completed NCT02657668 - Emotion Focused Therapy in Irritable Bowel Syndrome Patients N/A
Completed NCT02731664 - GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans Phase 1
Recruiting NCT06205446 - Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction N/A
Recruiting NCT05718960 - Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia N/A
Terminated NCT04247100 - A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders N/A
Recruiting NCT03625674 - Impact of Stigma on Compliance to Medication in Functional Dyspepsia N/A
Completed NCT03252743 - ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study. N/A
Recruiting NCT05832528 - Low FODMAP Diet in FD (PDS) N/A
Completed NCT02936713 - Effect of Controlled Diet Combined With a Fermented Milk Product on Gas-related Symptoms N/A
Terminated NCT01712412 - Phase 2a Study of IW-9179 to Treat Functional Dyspepsia Phase 2
Completed NCT00564525 - Study of Medication for Functional Abdominal Pain in Children Phase 4
Recruiting NCT05987813 - Transcutaneous Electric Nerve Stimulation (TENS) for Vagal Modulation N/A
Completed NCT04155801 - A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances N/A
Recruiting NCT05880199 - BSGM to Evaluate Patients With GI Symptoms
Recruiting NCT04625881 - Effects of an Apple Derived Fibre Supplement on Constipation Phase 3
Completed NCT03608735 - Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in Thailand
Recruiting NCT04773158 - Systematic Pediatric Assessment of Rome Criteria N/A
Completed NCT02306369 - Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents N/A